First-in-human Study of Mivebresib (ABBV-075), an Oral Pan-inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors.

CONCLUSIONS: Based on safety and tolerability, mivebresib RP2D is 1.5mg for the daily schedule, 2.5mg for 4/7 and 3mg for M-W-F. Mivebresib has a tolerable safety profile and stable disease was observed in some patients with malignant solid tumors. PMID: 31420359 [PubMed - as supplied by publisher]
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Tags: Clin Cancer Res Source Type: research

Related Links:

Abstract Inhaled pulmonary vasodilators are a powerful tool in the arsenal of therapies designed to treat pulmonary hypertension in pediatrics. Yet only 1 inhaled vasodilator, inhaled nitric oxide (INO), has been approved by the Food and Drug Administration for use in neonates> 34 weeks gestational age with persistent pulmonary hypertension of the newborn. Off-label use of inhaled vasodilators is common in the neonatal and pediatric population despite a lack of evidence. Growing focus on providing evidence-based therapies combined with the increasing cost of INO has led to the exploration of other inhaled pulmo...
Source: Respiratory Care - Category: Respiratory Medicine Authors: Tags: Respir Care Source Type: research
Abstract The purpose of this study was to evaluate the diagnostic performance of magnetic resonance (MR) radiomics-based machine learning algorithms in differentiating squamous cell carcinoma (SCC) from lymphoma in the oropharynx. MR images from 87 patients with oropharyngeal SCC (n=68) and lymphoma (n=19) were reviewed retrospectively. Tumors were semi-automatically segmented on contrast-enhanced T1-weighted images registered to T2-weighted images, and radiomic features (n=202) were extracted from contrast-enhanced T1- and T2-weighted images. The radiomics classifier was built using elastic-net regularized genera...
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Tags: Yonsei Med J Source Type: research
Abstract PURPOSE: Thrombocytopenia (platelet count
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Tags: Yonsei Med J Source Type: research
CONCLUSION: In real-world practice, pembrolizumab was feasible and effective in heavily treated recurrent gynecologic cancer patients with poor performance status who may not be eligible for enrollment in clinical trials. PMID: 32975058 [PubMed - in process]
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Tags: Yonsei Med J Source Type: research
Publication date: January 2021Source: Materials Science and Engineering: B, Volume 263Author(s): Nazire Altunkök, Özlem Biçen Ünlüer, Ebru Birlik Özkütük, Arzu Ersöz
Source: Materials Science and Engineering: B - Category: Materials Science Source Type: research
PMID: 32976145 [PubMed - as supplied by publisher]
Source: The American Journal of Nursing - Category: Nursing Authors: Tags: Am J Nurs Source Type: research
Publication date: Available online 25 September 2020Source: Biosensors and BioelectronicsAuthor(s): Roberta D'Agata, Noemi Bellassai, Matteo Allegretti, Andrea Rozzi, Saša Korom, Alex Manicardi, Elisa Melucci, Edoardo Pescarmona, Roberto Corradini, Patrizio Giacomini, Giuseppe Spoto
Source: Biosensors and Bioelectronics - Category: Biotechnology Source Type: research
Publication date: Available online 26 September 2020Source: Saudi Journal of Biological SciencesAuthor(s): Padmini Rajendran, Uma Maheshwari Nallal, Saravanan Parameswaran, Keun Woo Lee, Razia Muthuswamy, Mona S Alwahibi, B. Ravindran, Mohamed Soliman Elshikh, Young Ock Kim, Hyungsuk Kim, Hak-Jae Kim
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research
Publication date: Available online 14 September 2020Source: Life Sciences in Space ResearchAuthor(s): Luana Hafner, Linda Walsh, Uwe Schneider
Source: Life Sciences in Space Research - Category: Biology Source Type: research
Chem. Commun., 2020, Accepted Manuscript DOI: 10.1039/D0CC04957C, CommunicationMizuho Yasuda, Yue Ma, Sachiko Okabe, Yuki Wakabayashi, Dongdong Su, Young-Tae Chang, Hiroyuki Seimiya, Masayuki Tera, Kazuo Nagasawa Macrocyclic hexaoxazoles (6OTDs) are G-quadruplex (G4) ligands, and some derivatives, such as L2H2-6OTD (1a) bearing two aminobutyl side chains, show cytotoxicity towards cancer cells. To identify the cellular target of... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Colorectal Cancer | Eye Cancers | Gastroenterology | Hypertension | Melanoma | Oral Cancer | Pancreas | Pancreatic Cancer | Prostate Cancer | Skin Cancer | Study | Thrombocytopenia | Toxicology | Uveal Melanoma